Myofibrillar myopathy is a progressive muscle disease characterized by the disintegration of muscle fibers and formation of protein aggregates. Causative mutations have been identified in nine genes encoding Z-disk proteins, including the actin binding protein filamin C (FLNC). To investigate the mechanism of disease in 
Introduction
Myofibrillar myopathies are progressive muscle diseases characterized by disintegration of muscle fibers and abnormal protein accumulation. Myofibrillar myopathy patients present with progressive, relatively late onset, muscle weakness often accompanied by cardiomyopathy and/or respiratory complications. Causative mutations for myofibrillar myopathies have been identified in nine genes; desmin (1), αB-crystallin (2), myotilin (3), Z-band alternatively spliced PDZ motif-containing protein (ZASP; (4)), filamin C (FLNC; (5)), bcl-2-associated athanogene 3 (BAG3; (6) ), four and a half LIM domain 1 (FHL1; (7)), titin (8) , and actin (9) . All of these genes encode proteins found at the Z-disk, a key structure involved in the transmission of tension and contractile forces along the muscle fiber.
Given that protein aggregate formation is consistent between myofibrillar myopathies regardless of the genetic basis (10) , considerable effort has been put into their characterization. Using laser microdissection and proteomic analysis a range of sarcomeric and extra-sarcomeric proteins have been shown to be included within them, with the most abundant protein being the product of the gene mutated (11) (12) (13) .
Whilst the aggregates are a characteristic of the disease their characterization has not led to an understanding of their contribution to muscle weakness. We therefore investigated the mechanism of disease in myofibrillar myopathy caused by a mutation in the Z-disk protein FLNC.
FLNC belongs to the Filamin family of actin-binding proteins and is expressed predominantly in skeletal and cardiac muscle (14) . The majority of FLNC localizes to Page 4 of 46 the Z-disk, which is important in the maintenance of structural integrity of the sarcomere. A small fraction of FLNC localizes to the sarcolemma (14) , where it interacts with the transmembrane receptor β1-integrin (15) and components of the dystrophin-glycoprotein complex (14) . FLNC therefore connects components of the sarcolemma to the extracellular matrix, providing both a structural linkage and a mechanism for signal transduction.
The Filamin proteins, including FLNC, are highly conserved in their structure, containing two actin binding domains in the N-terminal region followed by 24 immunoglobulin (Ig) repeats (16) . The first identified and most prevalent myofibrillar myopathy causing FLNC mutation is FLNC W2710X which results in truncation of the last 16 amino acids of the 24 th Ig repeat that is important for dimerization (5) . Since this initial discovery four additional myofibrillar myopathy causing FLNC mutations have been identified all demonstrating autosomal dominant inheritance and ages of onset ranging from 24 to 60 (17) (18) (19) . More recently, mutations in FLNC have been identified in distal myopathy, resulting in fiber disintegration but not protein aggregation (20, 21) . The presentation of fiber disintegration in both FLNC-related myofibrillar and distal myopathies is suggestive of an overlap in the mechanism of disease.
The effect of the W2710X mutation has been thoroughly examined in vitro.
Biochemical studies revealed that a partial loss of the dimerization domain of FLNC W2710X disturbs its overall secondary structure, and although this has no effect on its actin binding capacity (20) 
FLNC W2710X demonstrates reduced dynamics at the Z-disk
Whilst the W2710X mutation does not affect FLNC localization or abolish the functions required for Z-disk integrity we wished to examine the dynamics of FLNC W2710X within the Z-disk to determine the impact of the mutation. We therefore performed fluorescent recovery after photobleaching experiments (FRAP) on five days post fertilisation (dpf) embryos expressing either FLNC wt -eGFP (Fig. 5A ) or FLNC W2710X -eGFP (Fig. 5B ). An initial examination of the recovery profiles demonstrated slower recovery of the mutant FLNC compared to wildtype, evident by differences in the slope of the curves (Fig. 5C ). To investigate this further, we analysed the data using two phase non-linear correlation, which determined the slow and fast half lives of FLNC recovery. In line with diffusion being the primary determinant of the fast half life, we found no significant difference between the fast bag3 MO + NH 4 Cl, n=187 fibers in 22 embryos; Fig. 8C ). These results demonstrate that rather than promoting the clearance of aggregates, BAG3 prevents the autophagic degradation of FLNC W2710X aggregates.
To directly examine autophagy induction, rather than its effect on aggregate number
we examined Lc3 accumulation in untreated and chloroquine treated bag3 morphant embryos ( Supplementary Fig. 2) . The reduced accumulation of Lc3 in chloroquine 
Stimulation of autophagy reduces protein aggregates
Despite an impairment of the BAG3-mediated CASA pathway we tested drugs that upregulate autophagy as a strategy to promote the clearance of aggregates. Embryos expressing FLNC wt -eGFP (Fig. 9A) Supplementary Fig. 3 ). This indicates a combination of autophagy stimulation and BAG3 depletion as a potentially powerful therapeutic strategy for FLNC-related MFM.
Discussion
To (20) , results in fiber disintegration and corresponding muscle weakness.
The mechanism we propose for FLNC W2710X myofibrillar myopathy is similar to the mechanism we recently reported for BAG3 P209L myofibrillar myopathy (27) . In both cases the formation of protein aggregates results in a reduction in the availability of the protein resulting in insufficiency and a loss of function phenotype. Given the similarity in mechanism between these two genetically different forms of myofibrillar myopathy and the highly consistent pathological presentation we suggest this mechanism could be further extended to other causes of myofibrillar myopathy. and treatment with autophagy promoting compounds suggests these may be effective therapies for FLNC W2710X myofibrillar myopathy, with the later potentially beneficial for the entire family of myofibrillar myopathies. 
Materials and Methods

Fish maintenance
Overexpression constructs
The full length FLNC wt -eGFP and FLNC W2710X -eGFP constructs were provided by Dr.
Peter van der Ven and Prof. Dieter Fűrst (24) and subsequently cloned under the actc1b promoter (51) to generate the final expression construct. The constructs were injected at 100ng/µl into one cell stage embryos. The final mCherry tagged actinin3b expression vector was generated using LR Gateway recombination with the actc1b promoter in the 5' entry cassette, full length zebrafish actinin3b in a modified form of middle entry cassette (52) and mCherry in the 3' cassette. Both, the actinin3b-mCherry and previously published BAG3-mcherry constructs (53) were injected at 50ng/µl into one cell stage embryos.
Immunohistochemistry and confocal microscopy
To determine localization of the tagged proteins within the sarcomere Page 20 of 46 immunohistochemistry was performed according to previously described protocols (26) . 4% paraformaldehyde (4% PFA) was used as a fixative for all antibody labels.
The primary antibodies used in this study were anti-eGFP (Invitrogen, A-11122, 1:150), anti-Actinin (Sigma, A7811, 1:100), anti-Myosin (DSHB, A4.1025, 1:10).
Embryos were mounted in 1% low melting point agarose and imaged using the Zeiss LSM 710 confocal microscope. The maximum intensity projections were obtained using Fiji (http://fiji.sc; (54))
Morpholino microinjections
All antisense morpholino oligonucleotides were obtained from Gene Tools and Fiji was used to determine fluorescence intensity of bleached and unbleached areas at each time point. The data was obtained in triplicate and the analysis was carried out as per (55) . Graphpad Prism was used to perform the two-phase non-linear regression analysis to determine the slow and fast half-lives and mobile fraction.
Drug treatments
Autophagy was examined by incubating 32-hpf embryos in chloroquine (Sigma; final concentration 100µM in E3 embryo medium), ammonium chloride (Sigma; final concentration 100mM in E3 embryo medium, (56) 
Western blot analysis
Protein lysates were obtained as per (57) and quantified using the Bradford assay.
50µg of each sample, along with reducing agent (Invitrogen) and protein loading dye (Life Technologies), was heated at 70 o C for 10 min, separated by SDS-PAGE on NuPAGE 4-12% Bis-Tris gels, and transferred onto PVDF membrane (Millipore).
Following transfer, the membrane was blocked with 5% skimmed milk in PBST and subsequently probed with anti-Lc3 (Novus Biologicals, NB100-2220, 1/2000) and 
Immuno Correlative Light Electron Microscopy (CLEM) sample preparation
Fixation and embedding of 2-day zebrafish emrbyos was performed according to the Tokuyasu method (58, 59) . Ultrathin cryo-sections were cut on a Leica FCS-UCT7.
The combined fluorescence-and immuno-labeling was carried out as described in 
